Method summary | DNA X-ray crystallography (direct) |
Requirements | 3G synchrotron facilities/microsource X-ray diffractometer. |
Results | Definitive visualization of metallodrug–DNA binding interactions. |
Advantages | Detailed structural data. |
Limitations | Solid-state interactions only and transient/dynamic/pre-associative interactions may be precluded. Crystals of suitable quality required. |
Complementary and advanced techniques | NMR and MS (direct) (Sections 2.2 and 2.3). CD/fluorescence/absorbance spectroscopy (indirect) (Sections 3.1 and 3.2). |
Advanced complementary methods include analysis by optical tweezers. |